Literature DB >> 15908696

The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol.

Elizabeth E Millard1, Sarah E Gale, Nicole Dudley, Jessie Zhang, Jean E Schaffer, Daniel S Ory.   

Abstract

The Niemann-Pick C1 (NPC1) protein is a key participant in intracellular sterol trafficking and regulation of cholesterol homeostasis. NPC1 contains a pentahelical region that is evolutionarily related to sterol-sensing domains found in other polytopic proteins involved in sterol interactions or sterol metabolism, including sterol regulatory element-binding protein cleavage-activating protein and hydroxymethylglutaryl-CoA reductase. To gain insight into the role of the sterol-sensing domain of NPC1, we examined the effect of point mutations in the NPC1 sterol-sensing domain on the trafficking of low density lipoprotein-derived cholesterol and sphingolipids. We show that an NPC1 P692S loss of function mutation results in decreased cholesterol delivery to the plasma membrane and endoplasmic reticulum. By contrast, NPC1 proteins carrying a L657F or D787N point mutation, which correspond to the activating SCAP L315F and D443N mutations, respectively, exhibit a gain of function phenotype. Specifically, cell lines expressing the NPC1 L657F or D787N mutations show a nearly 2-fold increase in the rates of low density lipoprotein cholesterol trafficking to the plasma membrane and to the endoplasmic reticulum, and more rapid suppression of sterol regulatory element-binding protein-dependent gene expression. Trafficking of sphingolipids is intact in the D787N and L657F cell lines. Our finding that D787N and L657F are activating NPC1 mutations provide evidence for a conserved mechanism for the sterol-sensing domain among cholesterol homeostatic proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908696     DOI: 10.1074/jbc.M414024200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

2.  Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.

Authors:  Nina H Pipalia; Kanagaraj Subramanian; Shu Mao; Harold Ralph; Darren M Hutt; Samantha M Scott; William E Balch; Frederick R Maxfield
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

Review 3.  Insights into the mechanisms of sterol transport between organelles.

Authors:  Bruno Mesmin; Bruno Antonny; Guillaume Drin
Journal:  Cell Mol Life Sci       Date:  2013-01-03       Impact factor: 9.261

4.  Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish.

Authors:  Tyler Schwend; Evyn J Loucks; Diana Snyder; Sara C Ahlgren
Journal:  J Lipid Res       Date:  2011-05-16       Impact factor: 5.922

Review 5.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

6.  Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo.

Authors:  Stephen D B Goldman; Jeffrey P Krise
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

7.  Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions.

Authors:  Sarah E Gale; Emily J Westover; Nicole Dudley; Kathiresan Krishnan; Sean Merlin; David E Scherrer; Xianlin Han; Xiuhong Zhai; Howard L Brockman; Rhoderick E Brown; Douglas F Covey; Jean E Schaffer; Paul Schlesinger; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

8.  MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein.

Authors:  Mark Charman; Barry E Kennedy; Nolan Osborne; Barbara Karten
Journal:  J Lipid Res       Date:  2009-10-29       Impact factor: 5.922

9.  Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

Authors:  Brett Tortelli; Hideji Fujiwara; Jessica H Bagel; Jessie Zhang; Rohini Sidhu; Xuntian Jiang; Nicole M Yanjanin; Roopa Kanakatti Shankar; Nuria Carillo-Carasco; John Heiss; Elizabeth Ottinger; Forbes D Porter; Jean E Schaffer; Charles H Vite; Daniel S Ory
Journal:  Hum Mol Genet       Date:  2014-06-25       Impact factor: 6.150

10.  Niemann-Pick type C disease proteins: orphan transporters or membrane rheostats?

Authors:  Andrew B Munkacsi; Anthony F Porto; Stephen L Sturley
Journal:  Future Lipidol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.